Pfizer, Flynn accused of charging the NHS ‘unfairly high prices’ for anti-epilepsy drug
UK Competition and Markets Authority provisionally finds drug companies broke competition law
Read More
Tag: competition law
CMA fines Advanz over ‘excessive and unfair’ pricing of thyroid drug
The £100m fine sends ‘a clear message’ to the pharma sector, said the CMA
Read More
CMA imposes substantial fines on pharma firms for overcharging the NHS
Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets
Read More
Tribunal upholds CMA’s decision to fine Lexon £1.2m
Company found to have broken competition law to drive up prices of antidepressant nortriptyline
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
